Danimer Scientific (DNMR)
(Delayed Data from NYSE)
$0.58 USD
0.00 (0.00%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $0.58 0.00 (0.69%) 7:14 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Danimer Scientific, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -155.47 | -179.76 | -60.11 | -12.57 | -19.51 |
Depreciation/Amortization & Depletion | 38.05 | 22.19 | 11.11 | 6.78 | 5.58 |
Net Change from Assets/Liabilities | 13.50 | -19.32 | -28.87 | -7.18 | 8.68 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 56.66 | 115.05 | 14.90 | -0.82 | 3.58 |
Net Cash From Operating Activities | -47.26 | -61.84 | -62.96 | -13.80 | -1.67 |
Property & Equipment | -27.66 | -164.43 | -184.99 | -38.26 | -35.69 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -0.01 | -151.18 | 0.00 | 0.00 |
Investments | 0.00 | -18.04 | 0.00 | 0.00 | -13.41 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -27.66 | -182.48 | -336.17 | -38.26 | -49.09 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.08 | -0.18 | 138.48 | 38.06 | 4.15 |
Issuance (Repayment) of Debt | 116.97 | 23.20 | 213.08 | 2.61 | 54.03 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -33.02 | -1.27 | -45.36 | 382.01 | -4.68 |
Net Cash from Financing Activities | 84.03 | 21.75 | 306.20 | 422.68 | 53.50 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 9.10 | -222.57 | -92.93 | 370.62 | 2.73 |
Cash at Beginning of Period | 64.40 | 286.97 | 379.90 | 9.28 | 6.55 |
Cash at End of Period | 73.50 | 64.40 | 286.97 | 379.90 | 9.28 |
Diluted Net EPS | -1.52 | -1.78 | -0.65 | -0.43 | NA |
Fiscal Year End for Danimer Scientific, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -27.26 | -155.47 | -116.04 | -75.88 |
Depreciation/Amortization & Depletion | NA | 10.31 | 38.05 | 27.94 | 18.00 |
Net Change from Assets/Liabilities | NA | 2.68 | 13.50 | 14.49 | 8.15 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.28 | 56.66 | 42.28 | 28.58 |
Net Cash From Operating Activities | NA | -12.99 | -47.26 | -31.33 | -21.15 |
Property & Equipment | NA | -1.97 | -27.66 | -25.70 | -23.04 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -1.97 | -27.66 | -25.70 | -23.04 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 13.53 | 0.08 | -0.06 | -0.06 |
Issuance (Repayment) of Debt | NA | -0.61 | 116.97 | 117.56 | 118.26 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.12 | -33.02 | -33.01 | -33.17 |
Net Cash from Financing Activities | NA | 13.04 | 84.03 | 84.49 | 85.03 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -1.92 | 9.10 | 27.45 | 40.84 |
Cash at Beginning of Period | NA | 73.50 | 64.40 | 64.40 | 64.40 |
Cash at End of Period | NA | 71.58 | 73.50 | 91.85 | 105.24 |
Diluted Net EPS | NA | -0.26 | -0.39 | -0.39 | -0.38 |